Toll-like receptor 4 knockout protects against diabetic-induced imbalance of bone metabolism via autophagic suppression.

[1]  D. Hurley,et al.  Lead alters intracellular protein signaling and suppresses pro-inflammatory activation in TLR4 and IFNR-stimulated murine RAW 264.7 cells, in vitro , 2019, Journal of toxicology and environmental health. Part A.

[2]  Sunjie Yan,et al.  Metformin alleviates hyperglycemia‐induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway , 2019, Life sciences.

[3]  Eun-Kyoung Kim,et al.  TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia , 2018, Autophagy.

[4]  Daishi Tian,et al.  Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1/6 pathway , 2018, Theranostics.

[5]  Z. Mao,et al.  p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1 , 2018, The Journal of cell biology.

[6]  H. Drissi,et al.  Overexpression of MiR‐335‐5p Promotes Bone Formation and Regeneration in Mice , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  A. Derer,et al.  Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis. , 2017, Bone.

[8]  M. Frost,et al.  Bone disease in diabetes: another manifestation of microvascular disease? , 2017, The lancet. Diabetes & endocrinology.

[9]  A. Ghosh,et al.  Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging , 2017, Aging.

[10]  T. Billiar,et al.  TLR4 Inactivation in Myeloid Cells Accelerates Bone Healing of a Calvarial Defect Model in Mice , 2017, Plastic and reconstructive surgery.

[11]  Yongchang Yao,et al.  Differential circRNA expression profiles during the BMP2-induced osteogenic differentiation of MC3T3-E1 cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Courtney M. Karner,et al.  Bmp Induces Osteoblast Differentiation through both Smad4 and mTORC1 Signaling , 2016, Molecular and Cellular Biology.

[13]  Jun Ren,et al.  Toll-like receptor 4 knockout alleviates paraquat-induced cardiomyocyte contractile dysfunction through an autophagy-dependent mechanism. , 2016, Toxicology letters.

[14]  Fei Liu,et al.  Melatonin suppresses autophagy in type 2 diabetic osteoporosis , 2016, Oncotarget.

[15]  Xiaoju Wang,et al.  High glucose induces autophagy of MC3T3-E1 cells via ROS-AKT-mTOR axis , 2016, Molecular and Cellular Endocrinology.

[16]  M. Isobe,et al.  Regulation of autophagy by Beclin 1 in the heart. , 2016, Journal of molecular and cellular cardiology.

[17]  Jasmine A. Nirody,et al.  Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics , 2016, Osteoporosis International.

[18]  S. Bathina,et al.  BDNF protects pancreatic β cells (RIN5F) against cytotoxic action of alloxan, streptozotocin, doxorubicin and benzo(a)pyrene in vitro. , 2016, Metabolism: clinical and experimental.

[19]  M. Bouxsein,et al.  Type 2 diabetes and the skeleton: new insights into sweet bones. , 2016, The lancet. Diabetes & endocrinology.

[20]  N. Zhang,et al.  Toll‐like receptor‐4‐mediated autophagy contributes to microglial activation and inflammatory injury in mouse models of intracerebral haemorrhage , 2015, Neuropathology and applied neurobiology.

[21]  Yongquan Wu,et al.  Toll-Like Receptor 4 Knockout Protects Against Isoproterenol-Induced Cardiac Fibrosis , 2015, Journal of cardiovascular pharmacology and therapeutics.

[22]  S. Devaraj,et al.  Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. , 2014, Journal of diabetes and its complications.

[23]  Jinxiang Zhang,et al.  Toll-Like Receptor 4 in Bone Marrow-Derived Cells Contributes to the Progression of Diabetic Retinopathy , 2014, Mediators of inflammation.

[24]  J. Elmquist,et al.  Hepatocyte Toll-like Receptor 4 Regulates Obesity-Induced Inflammation and Insulin Resistance , 2014, Nature Communications.

[25]  Charlotte E. Egan,et al.  Toll-like Receptor 4-mediated Endoplasmic Reticulum Stress in Intestinal Crypts Induces Necrotizing Enterocolitis* , 2014, The Journal of Biological Chemistry.

[26]  T. Billiar,et al.  Lipopolysaccharide Stimulates p62-Dependent Autophagy-Like Aggregate Clearance in Hepatocytes , 2014, BioMed research international.

[27]  Ru-Lin Huang,et al.  LPS-stimulated inflammatory environment inhibits BMP-2-induced osteoblastic differentiation through crosstalk between TLR4/MyD88/NF-κB and BMP/Smad signaling. , 2014, Stem Cells and Development.

[28]  A. Surolia,et al.  Methionine down‐regulates TLR4/MyD88/NF‐κB signalling in osteoclast precursors to reduce bone loss during osteoporosis , 2014, British Journal of Pharmacology.

[29]  X. Yang,et al.  Lipopolysaccharide (LPS)-induced autophagy is involved in the restriction of Escherichia coli in peritoneal mesothelial cells , 2013, BMC Microbiology.

[30]  Hai-tao Zhu,et al.  Selenium Attenuates High Glucose-Induced ROS/TLR-4 Involved Apoptosis of Rat Cardiomyocyte , 2013, Biological Trace Element Research.

[31]  Yi-jun Zhou,et al.  Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes. , 2013, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[32]  T. P. Neufeld,et al.  ULK1 induces autophagy by phosphorylating Beclin-1 and activating Vps34 lipid kinase , 2013, Nature Cell Biology.

[33]  H. Schwarcz,et al.  Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. , 2013, Bone.

[34]  A. Avogaro,et al.  An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy , 2013, Diabetologia.

[35]  R. Rizzoli,et al.  Physical activity increases bone mineral density in children with type 1 diabetes. , 2012, Medicine and science in sports and exercise.

[36]  L. Mccauley,et al.  Amelioration of type I diabetes‐induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival , 2012, Journal of cellular physiology.

[37]  A. Bazzocchi,et al.  Relationship between body composition, body mass index and bone mineral density in a large population of normal, osteopenic and osteoporotic women , 2011, La radiologia medica.

[38]  N. Charoenphandhu,et al.  Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. , 2011, World journal of diabetes.

[39]  Guido Kroemer,et al.  Autophagy and the integrated stress response. , 2010, Molecular cell.

[40]  Chengqun Huang,et al.  LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. , 2009, American journal of physiology. Heart and circulatory physiology.

[41]  V. Deretic,et al.  Toll‐like receptors control autophagy , 2008, The EMBO journal.

[42]  N. Eissa,et al.  Signaling pathway of autophagy associated with innate immunity , 2008, Autophagy.

[43]  S. Dinesh-Kumar,et al.  Autophagy takes its TOLL on innate immunity. , 2007, Cell host & microbe.

[44]  A. Sharafkhaneh,et al.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. , 2007, Immunity.

[45]  N. Lane,et al.  Epidemiology, etiology, and diagnosis of osteoporosis. , 2006, American journal of obstetrics and gynecology.

[46]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[47]  Roland Baron,et al.  BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  T. Matsuguchi,et al.  Gene Expression of Osteoclast Differentiation Factor Is Induced by Lipopolysaccharide in Mouse Osteoblasts Via Toll-Like Receptors1 , 2001, Journal of Immunology.

[49]  N. Charoenphandhu,et al.  Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption , 2016, The Journal of Physiological Sciences.